94 related articles for article (PubMed ID: 6263449)
1. Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach.
Choi NC; Doucette JA
Cancer; 1981 Jul; 48(1):101-9. PubMed ID: 6263449
[TBL] [Abstract][Full Text] [Related]
2. En-bloc irradiation of unresectable bronchogenic carcinomas and their regional lymphatics.
Flodgren P; Baldetorp L; Landberg T; Mercke C; Möller T; Svahn-Tapper G
Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):463-74. PubMed ID: 216237
[TBL] [Abstract][Full Text] [Related]
3. Radical radiation therapy of advanced lung cancer: evaluation of prognostic factors and results of continuous and split course treatment.
Emami B; Munzenrider JE; Lee DJ; Rene JB
Cancer; 1979 Aug; 44(2):446-56. PubMed ID: 224998
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the lung: an evaluation of the scalene node biopsy in relation to radiation therapy of the supraclavicular region.
Huber CM; DeGiorgi LS; Levitt SH; King ER
Cancer; 1972 Jan; 29(1):84-9. PubMed ID: 4332319
[No Abstract] [Full Text] [Related]
5. The value of supraclavicular area treatment in radiotherapeutic management of lung cancer.
Emami B; Lee DJ; Munzenrider JE
Cancer; 1978 Jan; 41(1):124-9. PubMed ID: 203376
[No Abstract] [Full Text] [Related]
6. Unresectable non-oat cell carcinoma of the lung: definitive radiation therapy.
Mantravadi RV; Gates JO; Crawford JN; Bajpai D; Trenkner JD; Jordan LN
Radiology; 1989 Sep; 172(3):851-5. PubMed ID: 2549566
[TBL] [Abstract][Full Text] [Related]
7. Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results.
Lee RE; Carr DT; Childs DS
AJR Am J Roentgenol; 1976 Jan; 126(1):116-22. PubMed ID: 175669
[TBL] [Abstract][Full Text] [Related]
8. External radiation in the management of superior sulcus tumor.
Van Houtte P; MacLennan I; Poulter C; Rubin P
Cancer; 1984 Jul; 54(2):223-7. PubMed ID: 6202389
[TBL] [Abstract][Full Text] [Related]
9. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
Perez CA; Pajak TF; Rubin P; Simpson JR; Mohiuddin M; Brady LW; Perez-Tamayo R; Rotman M
Cancer; 1987 Jun; 59(11):1874-81. PubMed ID: 3032394
[TBL] [Abstract][Full Text] [Related]
10. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
11. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
12. [Radiation therapy of brain tumors metastatic from bronchogenic carcinoma].
Sasai K; Ono K; Hiraoka M; Tsutsui K; Takahashi M; Abe M; Hamakawa J; Nadai C
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 May; 48(5):602-7. PubMed ID: 2842727
[No Abstract] [Full Text] [Related]
13. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
14. [The superior vena cava syndrome as an emergency in radiotherapy].
Beck C; Berberich W; Bauknecht A; Schnabel K
Strahlenther Onkol; 1990 Dec; 166(12):798-802. PubMed ID: 2176355
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus.
Collins TM; Ash DV; Close HJ; Thorogood J
Clin Radiol; 1988 May; 39(3):284-6. PubMed ID: 2456177
[TBL] [Abstract][Full Text] [Related]
16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy.
Schaake-Koning C; Schuster-Uitterhoeve L; Hart G; Gonzalez Gonzalez D
Int J Radiat Oncol Biol Phys; 1983 Jul; 9(7):1023-8. PubMed ID: 6863070
[TBL] [Abstract][Full Text] [Related]
18. Systemic radiation and split-course radiotherapy for non-small-cell bronchial carcinoma.
Qasim M
Clin Radiol; 1986 Jan; 37(1):51-3. PubMed ID: 3956094
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure in patients with inoperable carcinoma of the lung.
Stanley K; Cox JD; Petrovich Z; Paig C
Cancer; 1981 Jun; 47(11):2725-9. PubMed ID: 6266640
[No Abstract] [Full Text] [Related]
20. Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders.
Dellon AL; Ptovin C; Chretien PB
Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):500-11. PubMed ID: 164781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
